72 related articles for article (PubMed ID: 24205699)
1. [Development of the HbA1c international standardization of HbA1c measurement in Japan Diabetes Society].
Kashiwagi A
Rinsho Byori; 2013 Jul; 61(7):585-93. PubMed ID: 24205699
[TBL] [Abstract][Full Text] [Related]
2. HbA1c: a review of analytical and clinical aspects.
Weykamp C
Ann Lab Med; 2013 Nov; 33(6):393-400. PubMed ID: 24205486
[TBL] [Abstract][Full Text] [Related]
3. Innovations in HbA
Lenters-Westra E; English E
Clin Chem Lab Med; 2024 Mar; 62(4):753-761. PubMed ID: 37870921
[TBL] [Abstract][Full Text] [Related]
4. Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study.
Steffes M; Cleary P; Goldstein D; Little R; Wiedmeyer HM; Rohlfing C; England J; Bucksa J; Nowicki M
Clin Chem; 2005 Apr; 51(4):753-8. PubMed ID: 15684277
[TBL] [Abstract][Full Text] [Related]
5. HbA1c standardisation: history, science and politics.
John WG; Mosca A; Weykamp C; Goodall I
Clin Biochem Rev; 2007 Nov; 28(4):163-8. PubMed ID: 18392123
[TBL] [Abstract][Full Text] [Related]
6. Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012).
Imagawa A; Hanafusa T; Awata T; Ikegami H; Uchigata Y; Osawa H; Kawasaki E; Kawabata Y; Kobayashi T; Shimada A; Shimizu I; Takahashi K; Nagata M; Makino H; Maruyama T
J Diabetes Investig; 2012 Dec; 3(6):536-9. PubMed ID: 24843620
[TBL] [Abstract][Full Text] [Related]
7. Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, Second Report.
Goto A; Noto H; Noda M; Ueki K; Kasuga M; Tajima N; Ohashi K; Sakai R; Tsugane S; Hamajima N; Tajima K; Imai K; Nakagama H
Diabetol Int; 2016 Mar; 7(1):12-15. PubMed ID: 30603237
[TBL] [Abstract][Full Text] [Related]
8. HbA1c standardisation destination--global IFCC Standardisation. How, why, where and when--a tortuous pathway from kit manufacturers, via inter-laboratory lyophilized and whole blood comparisons to designated national comparison schemes.
Goodall I
Clin Biochem Rev; 2005 Feb; 26(1):5-19. PubMed ID: 16278773
[TBL] [Abstract][Full Text] [Related]
9. New glycemic targets for patients with diabetes from the Japan Diabetes Society.
Araki E; Haneda M; Kasuga M; Nishikawa T; Kondo T; Ueki K; Kadowaki T
Diabetol Int; 2016 Dec; 7(4):327-330. PubMed ID: 30603281
[TBL] [Abstract][Full Text] [Related]
10. Patient result monitoring of HbA
Rollborn N; Kultima K; Larsson A
Clin Chem Lab Med; 2024 Jun; ():. PubMed ID: 38860992
[TBL] [Abstract][Full Text] [Related]
11. Third Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on diabetes and cancer: summary of the results of a questionnaire survey of oncologists and diabetologists-secondary publication.
Goto A; Ohashi K; Noda M; Noto H; Ueki K; Inoue M; Nishimura R; Takahashi S; Ioka T; Oshima M; Fujibayashi K; Tsuji A; Kodaira M; Tamakoshi A; Mimori K; Tanabe Y; Hara E; Matsuo K; Murakami Y; Watada H
Diabetol Int; 2024 Jan; 15(1):5-18. PubMed ID: 38264218
[TBL] [Abstract][Full Text] [Related]
12. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values.
Kashiwagi A; Kasuga M; Araki E; Oka Y; Hanafusa T; Ito H; Tominaga M; Oikawa S; Noda M; Kawamura T; Sanke T; Namba M; Hashiramoto M; Sasahara T; Nishio Y; Kuwa K; Ueki K; Takei I; Umemoto M; Murakami M; Yamakado M; Yatomi Y; Ohashi H;
J Diabetes Investig; 2012 Feb; 3(1):39-40. PubMed ID: 24843544
[No Abstract] [Full Text] [Related]
13. A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes.
Bouchi R; Kondo T; Ohta Y; Goto A; Tanaka D; Satoh H; Yabe D; Nishimura R; Harada N; Kamiya H; Suzuki R; Yamauchi T
Diabetol Int; 2023 Jan; 14(1):1-14. PubMed ID: 36636161
[No Abstract] [Full Text] [Related]
14. Correction: A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes.
Bouchi R; Kondo T; Ohta Y; Goto A; Tanaka D; Satoh H; Yabe D; Nishimura R; Harada N; Kamiya H; Suzuki R; Yamauchi T
Diabetol Int; 2023 Oct; 14(4):446. PubMed ID: 37781468
[TBL] [Abstract][Full Text] [Related]
15. A note from the founder of
Lucy MC
JDS Commun; 2024 Jan; 5(1):3-4. PubMed ID: 38223388
[No Abstract] [Full Text] [Related]
16. [The worldwide standardization of hemoglobin A1c measurement: the current statement from the Japan Diabetes Society and the issues to be solved].
Amemiya S; Hoshino T
Rinsho Byori; 2013 Jul; 61(7):594-601. PubMed ID: 24205700
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis.
Nishimura R; Taniguchi M; Takeshima T; Iwasaki K
Adv Ther; 2022 Jan; 39(1):632-654. PubMed ID: 34846709
[TBL] [Abstract][Full Text] [Related]
18. Relationship between Oral Health Status and Bone Mineral Density in Community-Dwelling Elderly Individuals: A Cross-Sectional Study.
Takeda M; Matsuda Y; Ikebuchi K; Takeda M; Abe T; Tominaga K; Isomura M; Nabika T; Kanno T
Healthcare (Basel); 2021 Apr; 9(4):. PubMed ID: 33917239
[TBL] [Abstract][Full Text] [Related]
19. Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?
Foley JE; Bhosekar V; Kawamori R
Vasc Health Risk Manag; 2016; 12():9-12. PubMed ID: 26855580
[TBL] [Abstract][Full Text] [Related]
20. A retrospective, cross-sectional study of real-world values of cardiovascular risk factors using a healthcare database in Japan.
Shima D; Ii Y; Yamamoto Y; Nagayasu S; Ikeda Y; Fujimoto Y
BMC Cardiovasc Disord; 2014 Sep; 14():120. PubMed ID: 25231128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
